| scholarly article | Q13442814 |
| P50 | author | Dorry Segev | Q23881945 |
| P2093 | author name string | Daniel S Warren | |
| Robert A Montgomery | |||
| Christopher E Simpkins | |||
| Matthew Cooper | |||
| Karen E King | |||
| R Sue Shirey | |||
| J Keith Melancon | |||
| Warren R Maley | |||
| Tomasz Kozlowski | |||
| P2860 | cites work | Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols | Q35849009 |
| ABO-incompatible kidney transplantation | Q35889318 | ||
| ABO-incompatible kidney transplantation using both A2 and non-A2 living donors | Q44077744 | ||
| Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis | Q44228631 | ||
| Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab | Q44584381 | ||
| Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy | Q44989312 | ||
| Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers | Q47947404 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2570-2575 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment | |
| P478 | volume | 5 |
| Q46369133 | A novel approach to successful ABO-incompatible high-titer renal transplantation |
| Q35607565 | ABO Incompatible Kidney Transplantation-Current Status and Uncertainties |
| Q37803412 | ABO blood group incompatibility: a diminishing barrier to successful kidney transplantation? |
| Q40915460 | ABO-Incompatible Living Kidney Transplants: Evolution of Outcomes and Immunosuppressive Management |
| Q34903473 | Accommodation in renal transplantation: unanswered questions |
| Q36902090 | Accommodation of grafts: implications for health and disease |
| Q41845634 | Adult Living Donor Liver Transplantation with ABO-Incompatible Grafts: A German Single Center Experience |
| Q38267202 | An update on ABO-incompatible kidney transplantation |
| Q48230185 | Anti-Blood Group Antibodies in Intravenous Immunoglobulin May Complicate Interpretation of Antibody Titers in ABO-Incompatible Transplantation |
| Q37138338 | Cancer risk after ABO-incompatible living-donor kidney transplantation |
| Q38445752 | Comparative analysis of ABO-incompatible living donor kidney transplantation with ABO-compatible grafts: a single-center experience in Korea |
| Q36171175 | Current progress in ABO-incompatible kidney transplantation |
| Q64098171 | Current protocols and outcomes of ABO-incompatible kidney transplantation based on a single-center experience |
| Q41731036 | Desensitization with plasmapheresis and anti-Cd20 for ABO incompatible kidney transplantation from living donor: experience of a single center in Italy |
| Q44977180 | Does immunosuppressive pharmacotherapy affect isoagglutinin titers? |
| Q35543289 | Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients. |
| Q36835081 | Economic Impacts of ABO-Incompatible Live Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients |
| Q40100407 | Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: Advantages and disadvantages of rituximab pretreatment. |
| Q37485481 | Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys |
| Q46915315 | Heart transplantation across the antibodies against HLA and ABO. |
| Q37830813 | Immunohaematological and apheretic aspects of the first kidney transplant from a living, ABO-incompatible donor carried out in Italy |
| Q37678248 | Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange |
| Q28741418 | Incompatible live-donor kidney transplantation in the United States: results of a national survey |
| Q54481297 | Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience. |
| Q36967217 | Induction therapy in pediatric renal transplant recipients: an overview |
| Q38006827 | Innovative strategies in living donor kidney transplantation |
| Q37776364 | Isoagglutinin adsorption in ABO-incompatible transplantation |
| Q50045395 | Kidney Exchange Match Rates in a Large Multicenter Clearinghouse. |
| Q39173951 | Kidney paired exchange and desensitization: Strategies to transplant the difficult to match kidney patients with living donors |
| Q50137555 | Landscape of ABO-Incompatible Live Donor Kidney Transplantation in the US. |
| Q38172280 | Molecular deciphering of the ABO system as a basis for novel diagnostics and therapeutics in ABO incompatible transplantation |
| Q53610974 | Negative regulation of HLA-DR expression on endothelial cells by anti-blood group A/B antibody ligation and mTOR inhibition. |
| Q47778948 | Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation. |
| Q40245497 | Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: a retrospective study |
| Q35822937 | Outcomes of ABO-incompatible kidney transplantation in the United States |
| Q36422175 | Pediatric renal transplantation in a highly sensitised child-8 years on. |
| Q44944396 | Plasmapheresis as preconditioning protocol in an extremely high titer ABO incompatible renal transplant (ABOiRTx) case: A new prospect for chronic kidney disease patients in India |
| Q51830578 | Post-Transplantation Immunoadsorption Can Be Withheld in ABO-Incompatible Kidney Transplant Recipients. |
| Q33370836 | Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action |
| Q93039622 | Selective plasma exchange in ABO-incompatible kidney transplantation: comparison of substitution with albumin and partial substitution with fresh frozen plasma |
| Q38468859 | Short-term results of ABO-incompatible living donor kidney transplantation: comparison with ABO-compatible grafts |
| Q80485421 | Simple "closed-circuit" group-specific immunoadsorption system for ABO-incompatible kidney transplants |
| Q51113508 | Solving the organ shortage crisis: the 7th annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium. |
| Q42873915 | Specific antibody filter (SAF) binding capacity enhancement to remove anti‐A antibodies |
| Q35022239 | Strategies to increase the donor pool and access to kidney transplantation: an international perspective |
| Q34106158 | The generation and maintenance of serum alloantibody. |
| Q51738133 | The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience. |
| Q30458220 | Therapeutic apheresis in renal transplantation; current practices |
| Q43982164 | Vienna experience of ABO-incompatible living-donor kidney transplantation |
Search more.